These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3891900)

  • 1. Serological hepatitis A virus infections and ratio of clinical to serological infections in a controlled trial of pre-exposure prophylaxis with immune serum globulin.
    Kark JD; Bar-Shany S; Shor S; Merlinski L; Nili E
    J Epidemiol Community Health; 1985 Jun; 39(2):117-22. PubMed ID: 3891900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three-year incidence of non-B viral hepatitis morbidity in a controlled trial of pre-exposure immune serum globulin prophylaxis.
    Kark JD; Witztum E; Mazkin H; Nili E; Danon YL
    Infection; 1984; 12(4):251-5. PubMed ID: 6386693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of immune serum globulin in an outbreak of hepatitis A virus infection in adults.
    Green MS; Dotan K
    J Infect; 1988 Nov; 17(3):265-70. PubMed ID: 2851022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure prophylaxis with immune serum globulin for prevention of viral hepatitis in army recruits.
    Kark JD
    J Epidemiol Community Health; 1982 Sep; 36(3):176-82. PubMed ID: 6754845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-exposure prophylaxis of viral hepatitis with immune serum globulin in an endemic area. A trial in field units of the Israel Defence Forces.
    Kark JD
    Scand J Infect Dis; 1983; 15(1):3-6. PubMed ID: 6405480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical infection with hepatitis A in Peace Corps volunteers following immune globulin prophylaxis.
    Pierce PF; Cappello M; Bernard KW
    Am J Trop Med Hyg; 1990 May; 42(5):465-9. PubMed ID: 2160196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis A antibody prevalence among young adults in Israel--the decline continues.
    Gdalevich M; Grotto I; Mandel Y; Mimouni D; Shemer J; Ashkenazi I
    Epidemiol Infect; 1998 Oct; 121(2):477-9. PubMed ID: 9825802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin.
    Conrad ME; Lemon SM
    J Infect Dis; 1987 Jul; 156(1):56-63. PubMed ID: 3110307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent effect of immune serum globulin prophylaxis in the military on viral hepatitis incidence in the civilian population in Israel.
    Green MS; Block C
    J Epidemiol Community Health; 1989 Jun; 43(2):187-90. PubMed ID: 2592909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active versus passive immunization against hepatitis A in the Israel defence forces: a cost-benefit analysis.
    Gillis D; Yetiv N; Gdalevich M; Mimouni D; Ashkenazi I; Shpilberg O; Eldad A; Shemer J
    Vaccine; 2000 Jul; 18(26):3005-10. PubMed ID: 10825603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study.
    Lerman Y; Shohat T; Ashkenazi S; Almog R; Heering SL; Shemer J
    Clin Infect Dis; 1993 Sep; 17(3):411-4. PubMed ID: 8218682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An outbreak of hepatitis A during a military field training exercise.
    Rubertone MV; DeFraites RF; Krauss MR; Brandt CA
    Mil Med; 1993 Jan; 158(1):37-41. PubMed ID: 8382351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine testing for IgG antibodies against hepatitis A virus in Israel.
    Samuels N
    BMC Public Health; 2005 Jun; 5():60. PubMed ID: 15935104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A community outbreak of hepatitis A in a religious community in Indiana: failure of immune serum globulin to prevent the spread of infection.
    Aszkenasy OM
    Epidemiol Infect; 2000 Apr; 124(2):309-13. PubMed ID: 10813157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.
    Tseng YT; Chang SY; Liu WC; Sun HY; Wu CH; Wu PY; Lu CL; Hung CC; Chang SC
    Hepatology; 2013 May; 57(5):1734-41. PubMed ID: 23258666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit of mass prophylaxis with immune serum globulin to control waterborne hepatitis A: a case study.
    Egoz N
    Isr J Med Sci; 1986; 22(3-4):277-82. PubMed ID: 3091532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-HAV-specific immunoglobulins].
    Maniez-Montreuil M; Dupressoir-Burlet MV; Goudemand M
    Rev Fr Transfus Immunohematol; 1983 Nov; 26(5):531-8. PubMed ID: 6665414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute non-B hepatitis in the Israel Defence Forces: comparison of some epidemiologic features before and after the usage of preexposure immune serum globulin prophylaxis.
    Matzkin H
    Hepatology; 1987; 7(6):1330-2. PubMed ID: 3119454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trends in epidemiology of hepatitis in the Israel Defense Forces-- direction over several years].
    Gdalevich M; Gillis D; Mimouni D; Grotto I; Shpilberg O
    Harefuah; 2000 May; 138(9):755-7, 806, 805. PubMed ID: 10883230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viral hepatitis A: specific immunological aspects before and after exposure to risk].
    Laverdant C; Hainaut J; Dutertre J
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):167-9. PubMed ID: 6099083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.